Celsentri 150 mg (Maraviroc TABLET) 150 MG

Celsentri 150 mg tablets contain maraviroc, an antiretroviral medication used in HIV treatment. Learn about its uses, effects, and precautions.

Strength

150 MG

Pack Size

Manufacturer / TM Owner

VIIV HEALTHCARE ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Celsentri 150 mg tablets are primarily used in the treatment of HIV-1 infection. Maraviroc is often part of combination therapy to help manage the virus. This medication is specifically designed for patients who have certain types of HIV that are resistant to other treatments. Understanding what maraviroc is used for can help patients and healthcare providers make informed decisions about HIV management.

Side Effects

Common effects of Celsentri 150 mg tablets may include dizziness, nausea, and abdominal pain. Some individuals might experience headaches or fatigue. These effects can vary from person to person, and not everyone will experience them. It's important to monitor how your body responds to maraviroc and consult a healthcare provider if any effects are concerning.

Precautions & Warnings

Celsentri 150 mg tablets should be handled with care. It's important to follow the advice of a healthcare provider regarding its use. Patients with liver or heart conditions should discuss their medical history with a healthcare provider before starting maraviroc. Always store the medication as directed to maintain its effectiveness.

Avoid Interactions

Maraviroc can interact with other medications, including those metabolized by the liver. It's crucial to inform your healthcare provider about all medications you are taking. Alcohol and certain supplements might also interact with maraviroc, so it's best to discuss these with a healthcare provider to avoid potential complications.

Frequently Asked Questions

Celsentri 150 mg tablets are used in the treatment of HIV-1 infection, often as part of combination therapy.

Celsentri 150 mg tablets are taken orally, typically as directed by a healthcare provider.

Common side effects of maraviroc may include dizziness, nausea, and abdominal pain.

It's best to discuss alcohol consumption with your healthcare provider, as it may interact with maraviroc.

Store Celsentri 150 mg tablets as directed on the packaging or by your healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.